Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-25-035151
Filing Date
2025-09-16
Accepted
2025-09-16 19:22:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 7811
  Complete submission text file 0001140361-25-035151.txt   9272
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Subject) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89380 | Film No.: 251318463
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 54 ROAN LANE ST. LOUIS MO 63124
Business Address
Gueck William J. (Filed by) CIK: 0002085232 (see all company filings)

Type: SCHEDULE 13G